IMO, EUA will be granted next week. However, if w
Post# of 148175
However, if we are to continue with our Phase III s/c trial, that does not mean that then we will have to go to 390 enrollment, then wait 28 days for last patient to be injected, and then wait 2 to 3 weeks for conclusive Top Line Report analysis/publication.
Another Interim s/c analysis could be performed when enrollment get to 235 or 250 or 260 and these bigger numbers increase probability of statisical significant p value.
We were at 221 as of October 7th, maybe we are now at 240, 245???
Maybe the DSMC is presenlty adding patients beyond our 195 to an update Interim analysis?